Roswell Park Comprehensive Cancer Center President and CEO Candace S. Johnson, PhD, has been named to City & State’s 2022 Health Care Power 100 list, released today. The weekly news magazine counts Dr. Johnson — who has been at the helm of Roswell Park since — as one of the “New York leaders who are saving lives.”

Today, the Ride for Roswell, presented by the West Herr Automotive Group, launched registration for the 2022 event, which will take place on Saturday, June 25 at the University at Buffalo. Online registration is available at www.rideforroswell.org. 

Metastasis, or spread of a cancer tumor from one organ to another, is a complex process about which much is still unknown. A collaborative research team led by scientists from Roswell Park Comprehensive Cancer Center and Wake Forest University Baptist Medical Center has determined that a small protein, RAC1, actively recruits enzymes involved in nucleotide production to promote cancer metastasis. Their findings, published in Nature Communications, suggest that targeting this interaction may provide a new strategy for treating advanced cancers.

A study led by scientists at Roswell Park Comprehensive Cancer Center shows that chemotherapy after surgery for gastric adenocarcinoma is significantly associated with longer survival in patients with chemosensitive disease, but not in those with very sensitive or refractory disease. These findings, which were recently published in the journal JAMA Network Open, suggest that assessing how responsive a tumor appears to be to treatment with chemotherapy before surgery can be used to guide decisions regarding postoperative chemotherapy, thereby personalizing treatment of patients with this type of stomach cancer.